New hope for breast cancer patients: easing vaginal atrophy symptoms
NCT ID NCT05562518
First seen May 08, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study tests different local treatments for vaginal atrophy (dryness, pain, irritation) in 160 breast cancer patients who are on hormone therapy. The goal is to see which treatment works best to improve symptoms and quality of life over 12 weeks, while also checking hormone levels for safety. Participants must have breast cancer, be postmenopausal due to treatment, and have vaginal symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Hospital Ghent
Ghent, 9000, Belgium
Conditions
Explore the condition pages connected to this study.